Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of Endoscopically-Assisted Submucosal Administration of Autologous Adipose-Derived Regenerative Cells for the Treatment of Urethral Strictures

NCT01889888 is registered in ClinicalTrials.gov with Burnasyan Federal Medical Biophysical Center as lead sponsor.

NCT NCT01889888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01889888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of Endoscopically-Assisted Submucosal Administration of Autologous Adipose-Derived Regenerative Cells for the Treatment of Urethral Strictures
Lead sponsor
Burnasyan Federal Medical Biophysical Center
Phase
Phase 1/2
Overall status
Unknown status
Start date
June 30, 2013
Completion date
May 31, 2015
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

urethral strictures in males